Treatment experience with a novel 30-mm hydrostatic balloon in esophageal dysmotility: a multicenter retrospective analysis

Sloan, Joshua A.; Triggs, Joseph; Pandolfino, John E.; Dbouk, Mohamad; Gutierrez, Olaya I. Brewer; Zein, Mohamad El; Quader, Farhan; Ichkhanian, Yervant; Gyawali, C. Prakash; Rubenstein, Joel H.; Khashab, Mouen A.

doi:10.1016/j.gie.2020.04.076

Cited by 17 publications

(12 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Seven studies (Table 4) included patients with other major motility disorders than achalasia (ie, esophago‐gastric junction outflow obstruction: EGJOO) 13,30,35‐39 . One study 36 showed that patients with EGJOO on HRM and pathological TBE had a lower EGJ DI ( P = .03) than patients with EGJOO on HRM and normal TBE (LE 3) with a cutoff value of 2.0 mm 2 /mm Hg (NPV: 100% and PPV: 75%).…”

Section: Resultsmentioning

confidence: 99%

“…However, neither the addition of a proximal extension 20 nor final gastric extension 26 to the EGJ myotomy seemed to change EGJ DI (LE 3). Lastly, two studies 30,31 used a new EndoFLIP ® device, the EsoFLIP 330, to perform dilation of the EGJ in patients with achalasia. Success defined by ES < 3 was obtained in, respectively, 63.8% (23/36) and 85% (23/27) of patients at 6 months of dilatation without major adverse effect.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

The use of impedance planimetry (Endoscopic Functional Lumen Imaging Probe, EndoFLIP^®) in the gastrointestinal tract: A systematic review

Desprez

Roman

Leroi

et al. 2020

Neurogastroenterology Motil

View full text Add to dashboard Cite

Background and purpose The EndoFLIP® system is a method of delineating impedance and was first designed to investigate the characteristics of the esophago‐gastric junction. In the last decade, its use was widened to investigate other sphincteric and non‐sphincteric systems of the gastrointestinal tract. The objective of the present systematic review was to summarize the available data in literature on the use of the EndoFLIP® system in the gastrointestinal tract, including sphincteric and non‐sphincteric regions. We performed a systematic review in accordance with recommendations for systematic review using PRISMA guidelines without date restriction, until June 2020, using MEDLINE‐PubMed, Cochrane Library, and Google Scholar databases. Only articles written in English were included in the present review. Five hundred and six unique citations were identified from all database combined. Of those, 95 met the inclusion criteria. There was a lack of standardization among studies in terms of anesthetic drugs use, probe placement, and inflation protocol. In most cases, only small cohorts of patients were included. Most studies investigated the EGJ, with a potential use of the EndoFLIP® to identify a subgroup of patients with achalasia and for intraoperative assessment of treatment efficacy in achalasia. However, the use of EndoFLIP® in the esophageal body (esophageal panometry), other esophageal diseases (gastro‐esophageal reflux disease, eosinophilic esophagitis), and other sphincter regions (anal canal, pylorus) will need further confirmatory studies. The EndoFLIP® system provides detailed geometric data of the gastrointestinal lumen but further works are needed to determine its use in clinical practice.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

The use of impedance planimetry (Endoscopic Functional Lumen Imaging Probe, EndoFLIP^®) in the gastrointestinal tract: A systematic review

Desprez

Roman

Leroi

et al. 2020

Neurogastroenterology Motil

View full text Add to dashboard Cite

show abstract

“…In two recent studies, the EsoFLIP was shown to be successful (ES < 3) in 64–85% of patients at 6 months follow-up without major adverse effects. 50 , 51 EsoFLIP eliminates the need for fluoroscopy and degree of dilation can be individualized (e.g. dilation stopped when the waist of the balloon is effaced).…”

Section: Endoscopic Approachesmentioning

confidence: 99%

Insights into the endoscopic management of esophageal achalasia

Brindise

Khashab

Abiad

2021

Clin Med Insights Gastroenterol

Self Cite

View full text Add to dashboard Cite

Achalasia is a primary esophageal motility disorder characterized by the loss of inhibitory neurons in the myenteric plexus, resulting in impaired relaxation of the esophagogastric junction. Achalasia is an incurable disease, and the treatment modalities are aimed at disruption of the esophagogastric junction and vary widely from pharmacological to endoscopic to surgical. Traditional endoscopic therapy includes pneumatic dilation, botulinum toxin injection, and peroral endoscopic myotomy. This review aims to provide an overview of the endoscopic management of achalasia, while focusing on the utilization of peroral endoscopic myotomy and other novel approaches.

show abstract

“…Además, la medición del UGE-ID con la EndoFLIP en la acalasia facilita la evaluación de su respuesta al tratamiento (miotomía o dilatación neumática) con los resultados clínicos en el momento del tratamiento (57,60,61). El EsoFLIP 330 también sirve para realizar dilatación de la UGE en pacientes con acalasia y el éxito, que se define como un Eckardt < 3, se obtuvo en el 63 % de los pacientes, sin mayores eventos adversos (62,63).…”

Section: Medición Del Tamaño De La Estenosis Y Evaluación Del Efecto De Dilataciónunclassified

EndoFLIP: una nueva tecnología

Hani

Villarreal

Bejarano

et al. 2021

Rev colomb Gastroenterol

View full text Add to dashboard Cite

Mediante la distensión de un balón con líquido conductor, la sonda de imagen luminal funcional endoluminal (EndoFLIP) evalúa las propiedades biomecánicas como la distensibilidad, volumen, presión e inclusive diámetros de regiones esfinterianas como la unión gastroesofágica, píloro y ano. La mayor evidencia en la utilidad clínica de la EndoFLIP está en los trastornos de motilidad esofágica, principalmente para identificar acalasia cuando la manometría esofágica de alta resolución y otras imágenes no logran diagnosticarla e inclusive, mediante el programa de FLIP 2.0, caracteriza la acalasia en subtipos a partir de patrones de motilidad del esófago distal en respuesta a la distensión. Se ha demostrado recientemente que la EndoFLIP tiene un rol diagnóstico, pronóstico o terapéutico en otras patologías como la esofagitis eosinofílica, reflujo gastroesofágico, gastroparesia, durante la fundoplicatura y dilatación esofágica.

show abstract

Treatment experience with a novel 30-mm hydrostatic balloon in esophageal dysmotility: a multicenter retrospective analysis

Cited by 17 publications

References 12 publications

The use of impedance planimetry (Endoscopic Functional Lumen Imaging Probe, EndoFLIP^®) in the gastrointestinal tract: A systematic review

The use of impedance planimetry (Endoscopic Functional Lumen Imaging Probe, EndoFLIP^®) in the gastrointestinal tract: A systematic review

Insights into the endoscopic management of esophageal achalasia

EndoFLIP: una nueva tecnología

Contact Info

Product

Resources

About

Treatment experience with a novel 30-mm hydrostatic balloon in esophageal dysmotility: a multicenter retrospective analysis

Cited by 17 publications

References 12 publications

The use of impedance planimetry (Endoscopic Functional Lumen Imaging Probe, EndoFLIP®) in the gastrointestinal tract: A systematic review

The use of impedance planimetry (Endoscopic Functional Lumen Imaging Probe, EndoFLIP®) in the gastrointestinal tract: A systematic review

Insights into the endoscopic management of esophageal achalasia

EndoFLIP: una nueva tecnología

Contact Info

Product

Resources

About

The use of impedance planimetry (Endoscopic Functional Lumen Imaging Probe, EndoFLIP^®) in the gastrointestinal tract: A systematic review

The use of impedance planimetry (Endoscopic Functional Lumen Imaging Probe, EndoFLIP^®) in the gastrointestinal tract: A systematic review